Stem cells have undergone a long journey of discovery and development, beginning in the mid-20th century and continuing to the present day. Research into them has advanced significantly, leading to a deeper understanding of their therapeutic potential for various diseases, particularly neurological diseases.
In a world accelerating toward medical discoveries that are rewriting the future of treatment, regenerative medicine has emerged as a scientific paradise that holds the promise of treatments that were unimaginable years ago. While the United States has approved immunotherapy for cancer, which relies on stimulating the immune system to attack tumors, Europe has achieved success in using mesenchymal stem cells (MSCs) to treat incurable diseases. These scientific breakthroughs have transformed stem cells from a mere academic term into a tangible hope for millions of patients, especially those whose diseases are managed with medications that alleviate symptoms without addressing the root causes.
A medical journal published by the I.D. Institute for Stem Cell and Genome Research
A medical journal published by the I.D. Institute for Stem Cell and Genome Research
I.D. Educational Community
Join the I.D. Community, an interactive environment bringing together experts, alumni, and students. This community aims to:
Exchange Clinical Expertise: Discuss challenging medical cases to enhance treatment outcomes.
Discuss Cutting-edge Research: Explore contemporary debates such as Digital Twins, Gerontology, and AI in medicine.
Build Professional Networks: Connect with leaders in regenerative medicine and global health organizations.
I.D. Educational Community
Join the I.D. Community, an interactive environment bringing together experts, alumni, and students. This community aims to:
Exchange Clinical Expertise: Discuss challenging medical cases to enhance treatment outcomes.
Discuss Cutting-edge Research: Explore contemporary debates such as Digital Twins, Gerontology, and AI in medicine.
Build Professional Networks: Connect with leaders in regenerative medicine and global health organizations.
